2001-April Archives by Date

• Messages sorted by: [ thread ] [ subject ] [ author ]
• More info on this list...

Starting: Mon Apr 2 06:52:01 2001
Ending: Mon Apr 30 19:16:01 2001
Messages: 112

• [Pharm-policy] Brazil-Merck agreement   Fatima Suleman
• [Pharm-policy] Blair sides with drug giants   Alan Story
• [Pharm-policy] Bulk Procurement and Distribution System   Paul Davis
• [Pharm-policy] Patents in Africa - Abacavir, 3TC, AZT and Nevirapine   James Love
• [Pharm-policy] German news magazine FOCUS 02/04/2001 report on research in dev countries, drug pricing, SA court case   Prof. Udo Schuklenk
• [Pharm-policy] Re: do patents matter in Africa?   msmith@Oxfam.org.uk
• [Pharm-policy] TAC letter of U. of Minnesota on Ziagen   Mike Palmedo
• [Pharm-policy] MSF proposal on not for profit drug company   James Love
• [Pharm-policy] PhRMA report on sales abroad   James Love
• [Pharm-policy] MSF proposal on not for profit drug company   Susan Finston
• [Ip-health] Re: [Pharm-policy] MSF proposal on not for profit drug company   Alan Story
• [Ip-health] Re: [Pharm-policy] MSF proposal on not for profit drug company   Alan Story
• [Ip-health] Re: [Pharm-policy] MSF proposal on not for profit drug company   Susan Finston
• [Pharm-policy] PHRMA speaks   George M. Carter
• [Pharm-policy] Reuters on SA PMA Affidavit   Mike Palmedo
• [Pharm-policy] Perspectives on Harvard Proposal   Paul Davis
• [Ip-health] Re: [Pharm-policy] MSF proposal on not for profit drug company   Susan Finston
• [Pharm-policy] Susan/ad hominem attack?   George M. Carter
• [Pharm-policy] Implementation of Antiretroviral Therapy in the Developing World: Brazil and Beyond   Gonsalves, Gregg
• [Ip-health] Re: [Pharm-policy] MSF proposal on not for profit drug company   Alan Story
• [Ip-health] Re: [Pharm-policy] MSF proposal on not forprofit drug company   Alan Story
• [Ip-health] Re: [Pharm-policy] MSF proposal on not forprofit drug company   Alan Story
• [Pharm-policy] NIH vs. Pharma was: MSF proposal on not forprofit drug company   Gonsalves, Gregg
• [Pharm-policy] Re: NIH vs. Pharma was: MSF proposal on not forprofit drug company   Dean Baker
• [Pharm-policy] Sanders letter to World Bank on IPR (fwd)   Robert Weissman
• [Pharm-policy] query: IMF/WB and IP issues relating to AIDS treatment   Robert Naiman
• [Pharm-policy] $1 billion on for AIDS on table tonight in DC.   Paul Davis
• [Pharm-policy] Re: Remove-- Cancel subscription   Sydney Lewis
• [Pharm-policy] Technology Transfer Forum April 17-18   James Love
• [Pharm-policy] Firms spent $7.7 million on clinical research per orphan drug approval in 1997   James Love
• [Pharm-policy] Re: Disturbed   Alan Story
• [Ip-health] Re: [Pharm-policy] MSF proposal on not for profit drug company   Els Torreele
• [Pharm-policy] Re: NIH vs. Pharma was: MSF proposal on not forprofit drug company   Alan Story
• [Pharm-policy] Re: [Ip-health] Frist Amendment   Lyndamdee@aol.com
• [Pharm-policy] Rockefeller Foundation Press Release   Mike Palmedo
• [Pharm-policy] BBC on Norway meeting   James Love
• [Pharm-policy] Glaxo refuses to cut HIV drug prices more than 90%   James Love
• [Pharm-policy] Ramsey pricing   James Love
• [Pharm-policy] Aharonian: Gene Patents, MTAs, Generics; Zoloft; Taxol; Canada TRIPS   James Love
• [Pharm-policy] Various Norway talking points   James Love
• [Pharm-policy] Mali accepts 5-company initiative   Robert Weissman
• [Pharm-policy] To Fight AIDS, Use Both Treatment and Prevention   Gonsalves, Gregg
• [Pharm-policy] Norway: How to help the poor, really (and how not to)   James Love
• [Pharm-policy] New WTO Press Release on Norway Meeting   Mike Palmedo
• [Pharm-policy] TAC Submits Affidavit   James Love
• [Pharm-policy] Press Release: AIDS and New Trade Agreements   Paul Davis
• [Pharm-policy] Affidavit in the South Africa court case   James Love
• [Pharm-policy] Costs of HIV drug clinical trials cited in NDA   James Love
• [Pharm-policy] Sachs and Danzon at the Hosbjor meeting   James Love
• [Pharm-policy] Proposed TACD resolution on access to health care   James Love
• [Pharm-policy] Sachs, me and Haddad   James Love
• [Pharm-policy] Goozner in Slate on Andrew Sullivan and big pharma   James Love
• [Pharm-policy] Kremer and Glennerster in Cato on purchase fund   James Love
• [Pharm-policy] expanded access program   James Love
• [Pharm-policy] Bush nominated Heimbold Sweden ambassador   James Love
• [Pharm-policy] Ivory Coast to import generic AIDS drugs   James Love
• [Pharm-policy] NPR Lies Again   George M. Carter
• [Pharm-policy] Cipla starts $1-a-day AIDS drugs exports   Mike Palmedo
• [Pharm-policy] Pharmacists appeal for solution to drugs (South Africa) 4/18/01   steph
• [Pharm-policy] SA court case   James Love
• [Pharm-policy] CPT/Essential Action: Response on SA Case   Robert Weissman
• [Pharm-policy] Drug firms lose first battle in long and costly war   Mike Palmedo
• [Pharm-policy] Flawed analysis?   George M. Carter
• [Pharm-policy] MSF, TAC, Oxfam press release-SAfrica court case   ACCESS-Com
• [Pharm-policy] Uganda Urges Compensation for AIDS Research Costs   Mike Palmedo
• [Pharm-policy] U supports reducing price of Ziagen   Steph Kerimo
• [Pharm-policy] Re: [Ip-health] Uganda Urges Compensation for AIDS Research Costs   Gregg Gonsalves
• [Pharm-policy] NY Times: Despite Legal Victory, South Africa Hesitates on AIDS Drugs   Mike Palmedo
• [Pharm-policy] Salon.com: The drug companies' racket   Mike Palmedo
• [Pharm-policy] query- india patents   tom sebastian
• [Pharm-policy] Napster wants compulsory Net-licenses for music catalogs   James Love
• [Pharm-policy] Congress of Americas and Brazil drug case   Rob Lake
• [Pharm-policy] Congress of Americas and Brazil drug case   George M. Carter
• [Pharm-policy] Prices of ddi, d4T and Combivir in South Africa pharmacies   James Love
• [Pharm-policy] Congress of Americas and Brazil drug case   Joel Lexchin
• [Pharm-policy] How much $ to save 25 million lives?   Robert Naiman
• [Pharm-policy] Mbeki and Economics   Negar Azimi
• [Pharm-policy] Brazilian UN Human Rights resolution passes 52,0 with 1 (USA) abstention   James Love
• [Pharm-policy] Mbeki and Economics   Fatima Suleman
• [Pharm-policy] Gardiner Harris: AIDS Gaffes in Africa Come Back to Haunt Drug Industry at home   James Love
• [Pharm-policy] States forming own drug programs   Dean Hughson
• [Pharm-policy] Merck meeting in Adobe   Alacran7@aol.com
• [Pharm-policy] Global AIDS Strategy May Prove Elusive: Washington Post Article   Gonsalves, Gregg
• [Pharm-policy] Brazil, Roche & nelfinavir   Paul Davis
• [Pharm-policy] Geffen on BMS, ddi and d4t   James Love
• [Pharm-policy] Brazilian Drug Resolution Draws U.S. Criticism as IP Rights Threat   James Love
• [Pharm-policy] Brazilian Drug Resolution Draws U.S. Criticism as IP Rights Threat   James Love
• [Pharm-policy] AFP: Indian firms see bounty in cheap anti-AIDS drugs   Mike Palmedo
• [Pharm-policy] WP: Powell declines invitation to AIDS summit   Mike Palmedo
• [Pharm-policy] Important Kofi Anan Speech Today   Paul Davis
• [Pharm-policy] U.S./Brazil trade dispute   Michael Manoochehri
• [Pharm-policy] Phila Inquirer: Annan urges Africans to fight AIDS   Paul Davis
• [Pharm-policy] Powell Letter   Paul Davis
• [Pharm-policy] CNN: Brazil pushes AIDS fight Beyond Borders   Mike Palmedo
• [Pharm-policy] Boston Globe: Nigeria reaches deal with Indian firm to buy AIDS drugs   Mike Palmedo
• [Pharm-policy] Next steps against AIDS   Gonsalves, Gregg
• [Pharm-policy] [Ip-health] WSJ: Brazil Makes Name for Itself Pumping Out Cheap AIDS Drugs   Mike Palmedo
• [Pharm-policy] PBS NewsHour on AIDS in Africa   Gonsalves, Gregg
• [Pharm-policy] [Ip-health] WSJ: Brazil Makes Name for Itself Pumping Out Cheap AIDS Drugs   Mike Palmedo
• [Pharm-policy] African Leaders Back Less Costly AIDS Drugs,More Spending   James Love
• [Pharm-policy] [Ip-health] Friedman op-ed in NY Times   Mike Palmedo
• [Pharm-policy] [Ip-health] WP: Renamed Prozac Fuels Womens's Health Debate   Mike Palmedo
• [Pharm-policy] Re: [Ip-health] Friedman op-ed in NY Times   Prof. Udo Schuklenk
• [Pharm-policy] [Ip-health] ToC Developing World Bioethics   Prof. Udo Schuklenk
• [Pharm-policy] [Ip-health] Abuja Declaration on HIV/AIDS, TB and Other Related Infectious Diseases   Mike Palmedo
• [Pharm-policy] [Ip-health] could securities tax fund anti-AIDS efforts?   Robert Naiman
• [Pharm-policy] [Ip-health] Abuja Declaration on HIV/AIDS, TB and Other Related Infectious Diseases   Mike Palmedo
• [Pharm-policy] [Ip-health] could securities tax fund anti-AIDS efforts?   Robert Naiman
• [Pharm-policy] [Ip-health] WP: Renamed Prozac Fuels Womens's Health Debate   Mike Palmedo
• [Pharm-policy] [Ip-health] Friedman op-ed in NY Times   Mike Palmedo
• [Pharm-policy] Re: [Ip-health] Friedman op-ed in NY Times   Prof. Udo Schuklenk
• [Pharm-policy] [Ip-health] ToC Developing World Bioethics   Prof. Udo Schuklenk

Last message date: Mon Apr 30 19:16:01 2001
Archived on: Mon Apr 30 18:16:02 2001

• Messages sorted by: [ thread ] [ subject ] [ author ]
• More info on this list...